About Us

Harnessing the regenerative power of the human body to develop transformative medicines for CNS disorders

Our Mission

Our mission is to improve life health for people affected by CNS disorders by driving the regenerative power of the human body. Altering the progressive and debilitating course of these conditions by returning the brain to a healthier state will transcend the benefits offered by existing therapies and allow people to live the futures they deserve.

CNS drug development has long suffered from limited innovation and high failure rates, especially for drugs that strive to modify the underlying cause of disease. Developing successful therapies requires several factors, including a deep knowledge of underlying disease mechanisms, exceptional chemistry, insights into viable translational models and strategies to match the right patients to the most effective drugs. We have brought these elements together at Autobahn to make a real difference in the lives of people.

Leadership Team

Ashlee HeldrethSenior Director of Clinical Operation

Alida BarryVice President, Head of Regulatory Affairs

James M. RobinsonVice President, Biostatistics and Data Sciences

Will StrattonChief Business Officer

Gudarz Davar, M.D.Chief Medical Officer, Head of Research and Development

Betsy VaughnVice President, Head of People and Culture

Jason Harris, Ph.D.Chief Scientific Officer

John BorkholderChief Financial and Legal Officer

Kevin FinneyChairman, President and CEO

Board of Directors

Fred Cohen, M.D., D.PhilPartner and Chairman, Monograph Capital

Uwe Schoenbeck, Ph.D.Venture Partner, Canaan Partners

Philip DeSouza, M.D.Venture Partner, Newpath Partners

Thomas Cahill, M.D., Ph.D.Founder and Managing Partner, Newpath Partners

Scott GiacobelloChief Financial Officer, Aadi Bioscience, Inc.

Timothy AndersonManaging Director, Blue Owl Capital

Ben Cravatt, Ph.D.Professor and Gilula Chair of Chemical Biology, the Scripps Research Institute

Kristina BurowManaging Director, ARCH Venture Partners

Kevin FinneyChairman, President and CEO

Scientific Advisors

Roger S. McIntyre, M.D., FRCPCProfessor of Psychiatry and Pharmacology at the University of Toronto

Jonathan M. Meyer, M.D.Voluntary Clinical Professor, Department of Psychiatry, University of California, San Diego

Sanjay J. Mathew, M.D.Professor and Department Head, Psychiatry and Behavioral Sciences, Texas A&M University Naresh K. Vashisht College of Medicine

Stephen M. Stahl, MD, PhD, DSc (Hon.)Clinical Professor, University of California, Riverside School of Medicine

Catherine Jensen Peña, Ph.D.Assistant Professor, Princton Neuroscience Institute

Rakesh Jain, M.D., MPHClinical Professor, Texas Tech University School of Medicine

Andy Cutler, M.D.Clinical Associate Professor, State University of New York Upstate Medical University

Dan Iosifescu, M.D.Professor of Psychiatry, NYU Grossman School of Medicine, Director of Clinical Research Nathan Kline Institute for Psychiatric Research